<h2 class="spotlight">
	<a href="query?cmd=SearchEC&ec=2.7.1.11">EC 2.7.1.11</a><br />
	Phosphofructokinase
</h2>

<p>
	<a href="http://www.ebi.ac.uk/pdbe-srv/view/entry/3pfk/visualisation.html"
		target="_blank"
		style="float: right; margin: 5px">
		<img src="http://www.ebi.ac.uk/pdbe-srv/view/images/entry/3pfk_cbc200.png"
			border="0" style="width: 30em"
			alt="Phosphofructokinase from Bacillus stearothermophilus at 2.4 &Aring; resolution"/>
	</a>

	<b><i>Abstract:</i></b><br />
		Phosphofructokinase (PFK) catalyses the phosphorylation of
		<a href="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:15946"
		target="_blank">fructose 6-phosphate</a> to
		<a href="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:16905"
		target="_blank">fructose 1,6-bisphosphate</a>.
		Mammals, yeast and many protozoa and bacteria use ATP as the
		<a href="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:30930"
		target="_blank">phosphono</a> donor (EC 2.7.1.11):
</p>
<p style="margin: 0.5em 3em">
	ATP + <small>D</small>-fructose 6-phosphate = ADP + <small>D</small>-fructose 1,6-bisphosphate
</p>
<p>
    whereas plants and certain other protozoa and bacteria possess PFKs that use inorganic diphosphate
		(PP<sub>i</sub>) (<a href="query?cmd=SearchEC&ec=2.7.1.90">EC 2.7.1.90</a>):
</p>
<p style="margin: 0.5em 3em">
	diphosphate + <small>D</small>-fructose 6-phosphate
	= phosphate + <small>D</small>-fructose 1,6-bisphosphate
</p>
<p>
    In many cases, both types of enzyme are present in the same organism. The two PFK families
		share a distant common ancestor, and typically have about 20-25% sequence identity.
		Interestingly, trypanosomal ATP-dependent PFK belongs to the PP<sub>i</sub>-dependent PFK
		family by sequence similarity.
		<br/>
		The crystal structures of the bacterial PFKs have been studied in detail [1].
		Martinez-Oyanedel <i>et al</i>. recently reported the first crystal structure of a eukaryotic PFK [2].
		The structure of the ATP-dependent PFK from <i>Trypanosoma brucei</i> revealed an N-terminal
		domain which possesses a unique fold. In addition, the loop that is characteristic for
		trypanosomal PFKs (it is not present in the bacterial or human enzymes) has been found
		to be located immediately adjacent to the active site. This knowledge offers opportunities
		for structure-based drug discovery for the treatment of sleeping sickness and other diseases
		caused by the trypanosomatids.

</p>

<p style="margin-top: 1em">
	<b><i>References:</i></b>
	<ol>
		<li><div class="pubauthors">Evans, P.R., Farrants, G.W., Hudson, P.J. (1981)</div>
			<div class="pubtitle">Phosphofructokinase: structure and control.</div>
			<div class="pubjournal"><i>Philos. Trans. R. Soc. Lond. B</i> <b>293</b>, 53-62. [PMID:6115424]</div>
		</li>
		<li><div class="pubauthors">Martinez-Oyanedel, J., McNae, I.W., Nowicki, M.W., Keillor, J.W.,
				Michels, P.A., Fothergill-Gilmore, L.A. and Walkinshaw, M.D.</div>
			<div class="pubtitle">The first crystal structure of phosphofructokinase from a eukaryote:
				<i>Trypanosoma brucei</i>.</div>
			<div class="pubjournal"><a href="http://dx.doi.org/10.1016/j.jmb.2006.10.019"
				target="_blank"><i>J. Mol. Biol.</i>, in press</a>.</div>
		</li>
	</ol>
</p>
